+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In-Vitro Diagnostics Instrument Market - Global Forecast 2026-2032- Product Image
In-Vitro Diagnostics Instrument Market - Global Forecast 2026-2032- Product Image
Sale

In-Vitro Diagnostics Instrument Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904898
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The In-Vitro Diagnostics Instrument Market is projected to reach USD 14.99 Billion in 2026. It is expected to continue growing at a CAGR of 8.66%, reaching USD 24.78 Billion by 2032.

In-vitro diagnostics (IVD) instruments are central to modern healthcare because they convert biological specimens into clinically actionable information for disease detection, therapy selection, monitoring, and public health surveillance. The market spans immunoassay analyzers, clinical chemistry systems, hematology platforms, molecular diagnostic instruments, coagulation systems, microbiology automation, urinalysis equipment, and point-of-care testing devices used across hospitals, reference laboratories, blood banks, physician offices, and decentralized care settings.

Demand is supported by verified structural healthcare trends: aging populations, a rising burden of chronic diseases, continuing infectious disease surveillance, antimicrobial resistance, and the expansion of precision medicine. Industry growth is also shaped by laboratory consolidation, workflow automation, quality requirements, and stricter regulatory oversight such as the U.S. FDA framework for IVDs and the European Union In Vitro Diagnostic Regulation (IVDR).

Transformative Shifts in the IVD Instrument Landscape

The IVD instrument landscape is shifting from volume-driven testing toward integrated, automated, and clinically connected diagnostics. Laboratories are prioritizing high-throughput platforms, random-access testing, closed-tube sampling, automated sample preparation, and bidirectional connectivity with laboratory information systems to reduce turnaround time, support traceability, and improve reproducibility.

Decentralized testing is another defining shift. Point-of-care molecular, immunoassay, and chemistry platforms are moving testing closer to emergency departments, outpatient clinics, pharmacies, and remote-care environments. At the same time, regulatory scrutiny, cybersecurity expectations, reagent supply resilience, service uptime, and interoperability standards are becoming strategic buying criteria alongside analytical performance and total cost of ownership.

Cumulative Impact of Artificial Intelligence on IVD Instruments

Artificial intelligence is reshaping IVD instruments by improving image interpretation, assay optimization, predictive maintenance, workflow scheduling, quality control monitoring, and decision-support integration. AI-enabled digital pathology, hematology cell morphology, microbiology colony reading, and molecular result interpretation can help reduce manual review burden while supporting consistency across high-volume laboratories.

The cumulative impact of AI is most powerful when algorithms are combined with validated datasets, quality management systems, and explainable clinical workflows. Adoption depends on regulatory validation, bias monitoring, cybersecurity, data governance, and integration into laboratory information systems. Leaders that treat AI as a regulated clinical capability rather than a stand-alone software feature will be better positioned to create durable value.

Key Regional Insights Across Global IVD Instrument Markets

North America remains a leading IVD instrument region due to advanced laboratory infrastructure, high healthcare spending, early adoption of molecular diagnostics, and established reimbursement pathways for medically necessary testing. The United States anchors innovation through reference laboratories, academic medical centers, FDA-cleared diagnostic platforms, and precision medicine programs, while Canada emphasizes quality-assured diagnostics across public healthcare networks.

Europe is shaped by the EU IVDR, which has increased the importance of clinical evidence, post-market surveillance, traceability, and conformity assessment. Germany, France, Italy, Spain, and the United Kingdom support demand through established hospital systems and cancer, cardiometabolic, antimicrobial resistance, and infectious disease testing needs. Asia-Pacific is the fastest-changing opportunity zone, led by China, India, Japan, South Korea, Australia, and ASEAN economies investing in laboratory capacity, local manufacturing, digital health infrastructure, and universal health coverage expansion.

Latin America, the Middle East, and Africa present diversified opportunities tied to infectious disease diagnostics, private healthcare investment, and public health modernization. Brazil and Mexico are major Latin American demand centers, GCC countries are investing in advanced hospitals, national screening programs, and connected laboratories, and African markets require scalable, robust instruments suited to fragmented infrastructure, high communicable disease burden, and expanding regional laboratory networks.

Key Group Insights for ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN demand is driven by expanding hospital networks, rising private diagnostics, and government programs improving access to infectious disease, maternal health, and noncommunicable disease testing. The GCC is characterized by high investment in tertiary care, population screening, and digital health infrastructure, making automation, premium analyzers, reliable service support, and connected diagnostics especially relevant.

The European Union is defined by harmonized regulatory expectations under IVDR, making clinical evidence, traceability, post-market surveillance, and lifecycle compliance core supplier differentiators. BRICS countries represent large-volume opportunities due to population scale, chronic disease burden, tuberculosis and infectious disease surveillance, and local production priorities. G7 markets emphasize innovation, quality, reimbursement discipline, laboratory workforce efficiency, and AI-enabled automation, while NATO countries increasingly consider diagnostic resilience, supply security, and preparedness as part of broader health security planning.

Key Country Insights Across Major IVD Instrument Markets

The United States leads in high-complexity testing, molecular diagnostics, oncology companion diagnostics, and laboratory automation, supported by reference laboratories, hospital networks, and precision medicine adoption. Canada prioritizes standardized, quality-assured testing across provincial systems, while Mexico and Brazil are expanding private diagnostics and public laboratory capacity for infectious disease, diabetes, cardiovascular disease, and oncology testing.

In Europe, the United Kingdom, Germany, France, Italy, and Spain remain core demand centers for clinical chemistry, immunoassay, hematology, microbiology, and molecular platforms. Germany benefits from strong engineering and laboratory infrastructure, France and the United Kingdom emphasize public health and hospital modernization, while Italy and Spain continue investing in efficient diagnostics for aging populations. Russia maintains demand for domestic capacity and essential diagnostic platforms amid localization pressures.

China is scaling domestic IVD innovation and hospital testing capacity, India is expanding affordable diagnostics across urban and semi-urban settings, Japan prioritizes high-quality automated systems for an aging society, South Korea is strong in molecular diagnostics and export-oriented manufacturing, and Australia combines advanced reference laboratories with public health surveillance and decentralized access needs.

Actionable Recommendations for IVD Industry Leaders

Industry leaders should prioritize platforms that combine analytical accuracy, automation, connectivity, cybersecurity readiness, and scalable menu expansion. Product strategies should address both centralized high-throughput laboratories and decentralized care settings, with differentiated configurations for hospitals, reference labs, emergency departments, outpatient clinics, and point-of-care environments.

Manufacturers should strengthen regulatory intelligence, IVDR readiness, FDA submission planning, cybersecurity controls, quality management systems, and post-market evidence generation. Commercial teams should build value propositions around turnaround time, labor savings, uptime, reagent efficiency, total cost of ownership, and clinical impact. Partnerships with laboratories, health systems, AI developers, and regional distributors can accelerate adoption while improving localization, training, and service resilience.

Research Methodology for IVD Instrument Market Analysis

This executive summary is developed using a structured research approach that integrates secondary research, regulatory review, industry benchmarking, and evidence triangulation. Inputs include public health data from organizations such as WHO and CDC, regulatory frameworks from FDA and European authorities, peer-reviewed clinical literature, reimbursement context, healthcare infrastructure indicators, and published health system priorities.

The methodology evaluates demand drivers, instrument categories, end-user adoption, regional health priorities, competitive positioning, technology readiness, and policy developments. Insights are validated through cross-source comparison to avoid reliance on single-point assumptions. The analysis emphasizes evidence-backed trends, practical market implications, and commercially relevant opportunities for stakeholders across the IVD instrument value chain without using market sizing or forecasting claims.

Conclusion: IVD Instruments as a Foundation of Precision Healthcare

The in-vitro diagnostics instrument market is entering a phase where clinical value, automation, AI readiness, regulatory compliance, and supply resilience are inseparable. Instruments are no longer evaluated only by test throughput or menu size; buyers increasingly assess workflow impact, data integration, quality assurance, service reliability, cybersecurity, and the ability to support precision medicine and public health preparedness.

Organizations that invest in connected platforms, validated AI, decentralized testing models, robust quality systems, and region-specific commercialization strategies will be better positioned to support healthcare transformation. As healthcare systems pursue earlier diagnosis, faster treatment decisions, and more efficient laboratory operations, IVD instruments will remain foundational to evidence-based medicine worldwide.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. In-Vitro Diagnostics Instrument Market, by Instrument Type
7.1. Introduction
7.2. Chemistry Analyzer
7.3. Coagulation Analyzer
7.4. Hematology Analyzer
7.5. Immunoassay Analyzer
7.6. Microbiology Analyzer
7.7. Molecular Diagnostics
7.8. Point Of Care
8. In-Vitro Diagnostics Instrument Market, by Technology
8.1. Introduction
8.2. Chromatography
8.2.1. Affinity Chromatography
8.2.2. Gas Chromatography
8.2.3. Ion Exchange Chromatography
8.2.4. Liquid Chromatography
8.3. Cytometry
8.3.1. Flow Cytometry
8.3.2. Image Cytometry
8.4. Immunoassay
8.4.1. Chemiluminescence
8.4.2. Enzyme Linked Immunosorbent Assay
8.4.3. Fluorescence Immunoassay
8.4.4. Turbidimetric Immunoassay
8.5. Microscopy
8.5.1. Confocal Microscopy
8.5.2. Electron Microscopy
8.5.3. Light Microscopy
8.6. Molecular
8.6.1. Hybridization
8.6.2. Microarray
8.6.3. Next Generation Sequencing
8.6.4. Pcr
8.7. Spectrometry
8.7.1. Fluorescence Spectroscopy
8.7.2. Mass Spectrometry
8.7.3. Uv Visible Spectroscopy
9. In-Vitro Diagnostics Instrument Market, by Configuration
9.1. Introduction
9.2. Benchtop
9.3. Floor Standing
9.4. Handheld
9.5. Portable
10. In-Vitro Diagnostics Instrument Market, by Level Of Automation
10.1. Introduction
10.2. Manual
10.3. Semi-Automated
10.4. Fully Automated
11. In-Vitro Diagnostics Instrument Market, by Application
11.1. Introduction
11.2. Infectious Disease
11.2.1. Respiratory Infections
11.2.2. Sexually Transmitted Infections
11.2.3. Healthcare-Associated Infections
11.3. Oncology
11.3.1. Solid Tumors
11.3.2. Hematologic Malignancies
11.4. Cardiology
11.4.1. Cardiac Markers
11.4.2. Lipid Testing
11.5. Diabetes
11.5.1. Glucose Monitoring
11.5.2. HbA1c Testing
11.6. Autoimmune Disease
11.6.1. Autoantibody Testing
11.6.2. Inflammatory Marker Testing
11.7. Nephrology
11.7.1. Renal Function Testing
11.7.2. Urine Chemistry Testing
11.8. Women's Health
11.8.1. Prenatal Screening
11.8.2. Fertility Testing
11.9. Drug Screening
11.9.1. Drugs Of Abuse Testing
11.9.2. Therapeutic Drug Monitoring
12. In-Vitro Diagnostics Instrument Market, by End User
12.1. Introduction
12.2. Academic Research
12.3. Diagnostic Laboratories
12.4. Hospitals
13. In-Vitro Diagnostics Instrument Market, by Region
13.1. Asia-Pacific
13.2. Europe
13.3. North America
13.4. Latin America
13.5. Africa
13.6. Middle East
14. In-Vitro Diagnostics Instrument Market, by Group
14.1. NATO
14.2. G7
14.3. European Union
14.4. BRICS
14.5. ASEAN
14.6. GCC
15. In-Vitro Diagnostics Instrument Market, by Country
15.1. United States
15.2. China
15.3. Germany
15.4. Japan
15.5. India
15.6. United Kingdom
15.7. France
15.8. Canada
15.9. Italy
15.10. Australia
15.11. South Korea
15.12. Brazil
15.13. Mexico
15.14. Russia
15.15. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. A. Menarini Diagnostics S.r.l.
17.2. Abbott Laboratories
17.3. Agilent Technologies, Inc.
17.4. ARKRAY, Inc.
17.5. Becton, Dickinson and Company
17.6. Bio-Rad Laboratories, Inc.
17.7. BioMérieux S.A.
17.8. Danaher Corporation
17.9. DiaSorin S.p.A.
17.10. EKF GmbH
17.11. F. Hoffmann-La Roche Ltd
17.12. Fujirebio Holdings, Inc.
17.13. Hologic, Inc.
17.14. Illumina, Inc.
17.15. Mesolonghi Diagnostics
17.16. Mindray Medical International Limited
17.17. PerkinElmer, Inc.
17.18. PHC Corporation
17.19. Qiagen N.V.
17.20. Roche Diagnostics
17.21. Seegene Inc.
17.22. Siemens Healthineers AG
17.23. Sysmex Corporation
17.24. Thermo Fisher Scientific Inc.
17.25. Tulip Diagnostics (P) Ltd
List of Figures
FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY INSTRUMENT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY INSTRUMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CONFIGURATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY LEVEL OF AUTOMATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY LEVEL OF AUTOMATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY INSTRUMENT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CHEMISTRY ANALYZER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CHEMISTRY ANALYZER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CHEMISTRY ANALYZER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL COAGULATION ANALYZER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL COAGULATION ANALYZER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL COAGULATION ANALYZER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL HEMATOLOGY ANALYZER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL HEMATOLOGY ANALYZER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL HEMATOLOGY ANALYZER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL IMMUNOASSAY ANALYZER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL IMMUNOASSAY ANALYZER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL IMMUNOASSAY ANALYZER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL MICROBIOLOGY ANALYZER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL MICROBIOLOGY ANALYZER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL MICROBIOLOGY ANALYZER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL POINT OF CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL POINT OF CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL POINT OF CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CHROMATOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CHROMATOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL AFFINITY CHROMATOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL AFFINITY CHROMATOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL AFFINITY CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL GAS CHROMATOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL GAS CHROMATOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL GAS CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ION EXCHANGE CHROMATOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ION EXCHANGE CHROMATOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ION EXCHANGE CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL LIQUID CHROMATOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL LIQUID CHROMATOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL LIQUID CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CYTOMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CYTOMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CYTOMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL IMAGE CYTOMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL IMAGE CYTOMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL IMAGE CYTOMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL CHEMILUMINESCENCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL CHEMILUMINESCENCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL CHEMILUMINESCENCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL ENZYME LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ENZYME LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ENZYME LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL FLUORESCENCE IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL FLUORESCENCE IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL FLUORESCENCE IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL TURBIDIMETRIC IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL TURBIDIMETRIC IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL TURBIDIMETRIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL MICROSCOPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL MICROSCOPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL MICROSCOPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL CONFOCAL MICROSCOPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL CONFOCAL MICROSCOPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CONFOCAL MICROSCOPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL ELECTRON MICROSCOPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL ELECTRON MICROSCOPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL ELECTRON MICROSCOPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL LIGHT MICROSCOPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL LIGHT MICROSCOPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL LIGHT MICROSCOPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL MOLECULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL MOLECULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL MOLECULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL HYBRIDIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL HYBRIDIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL MICROARRAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL MICROARRAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL MICROARRAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL PCR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL PCR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL SPECTROMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL SPECTROMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL SPECTROMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL FLUORESCENCE SPECTROSCOPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL FLUORESCENCE SPECTROSCOPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL FLUORESCENCE SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL UV VISIBLE SPECTROSCOPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL UV VISIBLE SPECTROSCOPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL UV VISIBLE SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL BENCHTOP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL BENCHTOP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL BENCHTOP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL FLOOR STANDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL FLOOR STANDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL FLOOR STANDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL HANDHELD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL HANDHELD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL HANDHELD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL PORTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL PORTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL PORTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL MANUAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL MANUAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL MANUAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL FULLY AUTOMATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL FULLY AUTOMATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL FULLY AUTOMATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL RESPIRATORY INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL RESPIRATORY INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL RESPIRATORY INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL SEXUALLY TRANSMITTED INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL SEXUALLY TRANSMITTED INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL SEXUALLY TRANSMITTED INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL HEALTHCARE-ASSOCIATED INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL HEALTHCARE-ASSOCIATED INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL HEALTHCARE-ASSOCIATED INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL SOLID TUMORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL SOLID TUMORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL SOLID TUMORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL CARDIAC MARKERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL CARDIAC MARKERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL CARDIAC MARKERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL LIPID TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL LIPID TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL LIPID TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL GLUCOSE MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL HBA1C TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 165. GLOBAL HBA1C TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 166. GLOBAL HBA1C TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 167. GLOBAL AUTOIMMUNE DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL AUTOIMMUNE DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 169. GLOBAL AUTOIMMUNE DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 170. GLOBAL AUTOANTIBODY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 171. GLOBAL AUTOANTIBODY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 172. GLOBAL AUTOANTIBODY TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 173. GLOBAL INFLAMMATORY MARKER TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 174. GLOBAL INFLAMMATORY MARKER TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 175. GLOBAL INFLAMMATORY MARKER TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 176. GLOBAL NEPHROLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 177. GLOBAL NEPHROLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 178. GLOBAL NEPHROLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 179. GLOBAL RENAL FUNCTION TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 180. GLOBAL RENAL FUNCTION TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 181. GLOBAL RENAL FUNCTION TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 182. GLOBAL URINE CHEMISTRY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 183. GLOBAL URINE CHEMISTRY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 184. GLOBAL URINE CHEMISTRY TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 185. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 186. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 187. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 188. GLOBAL PRENATAL SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 189. GLOBAL PRENATAL SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 190. GLOBAL PRENATAL SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 191. GLOBAL FERTILITY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 192. GLOBAL FERTILITY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 193. GLOBAL FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 194. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 195. GLOBAL DRUG SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 196. GLOBAL DRUG SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 197. GLOBAL DRUGS OF ABUSE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 198. GLOBAL DRUGS OF ABUSE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 199. GLOBAL DRUGS OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 200. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 201. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 202. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 203. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 204. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 205. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 206. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 207. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 208. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 209. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 210. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 211. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 212. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 213. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY INSTRUMENT TYPE, 2017-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MICROSCOPY, 2017-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 224. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY AUTOIMMUNE DISEASE, 2017-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY NEPHROLOGY, 2017-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY WOMEN'S HEALTH, 2017-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY DRUG SCREENING, 2017-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 235. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 236. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY INSTRUMENT TYPE, 2017-2032 (USD MILLION)
TABLE 237. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 238. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 239. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 240. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 241. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MICROSCOPY, 2017-2032 (USD MILLION)
TABLE 242. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 243. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 244. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 245. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 246. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 247. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 248. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 249. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 250. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 251. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY AUTOIMMUNE DISEASE, 2017-2032 (USD MILLION)
TABLE 252. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY NEPHROLOGY, 2017-2032 (USD MILLION)
TABLE 253. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY WOMEN'S HEALTH, 2017-2032 (USD MILLION)
TABLE 254. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY DRUG SCREENING, 2017-2032 (USD MILLION)
TABLE 255. EUROPE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 256. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 257. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY INSTRUMENT TYPE, 2017-2032 (USD MILLION)
TABLE 258. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 259. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 260. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 261. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 262. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MICROSCOPY, 2017-2032 (USD MILLION)
TABLE 263. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 264. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 265. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 266. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 267. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 268. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 269. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 270. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 271. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 272. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY AUTOIMMUNE DISEASE, 2017-2032 (USD MILLION)
TABLE 273. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY NEPHROLOGY, 2017-2032 (USD MILLION)
TABLE 274. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY WOMEN'S HEALTH, 2017-2032 (USD MILLION)
TABLE 275. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY DRUG SCREENING, 2017-2032 (USD MILLION)
TABLE 276. NORTH AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 277. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 278. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY INSTRUMENT TYPE, 2017-2032 (USD MILLION)
TABLE 279. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 280. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 281. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 282. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 283. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MICROSCOPY, 2017-2032 (USD MILLION)
TABLE 284. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 285. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 286. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 287. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 288. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 289. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 290. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 291. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 292. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 293. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY AUTOIMMUNE DISEASE, 2017-2032 (USD MILLION)
TABLE 294. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY NEPHROLOGY, 2017-2032 (USD MILLION)
TABLE 295. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY WOMEN'S HEALTH, 2017-2032 (USD MILLION)
TABLE 296. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY DRUG SCREENING, 2017-2032 (USD MILLION)
TABLE 297. LATIN AMERICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 298. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 299. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY INSTRUMENT TYPE, 2017-2032 (USD MILLION)
TABLE 300. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 301. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 302. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 303. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 304. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MICROSCOPY, 2017-2032 (USD MILLION)
TABLE 305. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 306. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 307. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 308. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 309. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 310. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 311. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 312. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 313. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 314. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY AUTOIMMUNE DISEASE, 2017-2032 (USD MILLION)
TABLE 315. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY NEPHROLOGY, 2017-2032 (USD MILLION)
TABLE 316. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY WOMEN'S HEALTH, 2017-2032 (USD MILLION)
TABLE 317. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY DRUG SCREENING, 2017-2032 (USD MILLION)
TABLE 318. AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 319. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 320. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY INSTRUMENT TYPE, 2017-2032 (USD MILLION)
TABLE 321. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 322. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 323. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 324. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 325. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MICROSCOPY, 2017-2032 (USD MILLION)
TABLE 326. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 327. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 328. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 329. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 330. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 331. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 332. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 333. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 334. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 335. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY AUTOIMMUNE DISEASE, 2017-2032 (USD MILLION)
TABLE 336. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY NEPHROLOGY, 2017-2032 (USD MILLION)
TABLE 337. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY WOMEN'S HEALTH, 2017-2032 (USD MILLION)
TABLE 338. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY DRUG SCREENING, 2017-2032 (USD MILLION)
TABLE 339. MIDDLE EAST IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 340. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 341. NATO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 342. NATO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY INSTRUMENT TYPE, 2017-2032 (USD MILLION)
TABLE 343. NATO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 344. NATO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 345. NATO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 346. NATO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 347. NATO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MICROSCOPY, 2017-2032 (USD MILLION)
TABLE 348. NATO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 349. NATO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 350. NATO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 351. NATO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY LEVEL OF AUTOMATION, 2017-2032 (USD MILLION)
TABLE 352

Companies Mentioned

  • A. Menarini Diagnostics S.r.l.
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • ARKRAY, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioMérieux S.A.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • EKF GmbH
  • F. Hoffmann-La Roche Ltd
  • Fujirebio Holdings, Inc.
  • Hologic, Inc.
  • Illumina, Inc.
  • Mesolonghi Diagnostics
  • Mindray Medical International Limited
  • PerkinElmer, Inc.
  • PHC Corporation
  • Qiagen N.V.
  • Roche Diagnostics
  • Seegene Inc.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Tulip Diagnostics (P) Ltd

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 14.99 Billion
Forecasted Market Value ( USD ) by 2032 $ 24.78 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

In-Vitro Diagnostics Quality Control Market - Global Forecast 2026-2032 - Product Image

In-Vitro Diagnostics Quality Control Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
In-Vitro Diagnostics Market - Global Forecast 2026-2032 - Product Image

In-Vitro Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
In Vitro Diagnostics - Global Strategic Business Report - Product Image

In Vitro Diagnostics - Global Strategic Business Report

  • Report
  • 586 Pages
  • Global
From
Infectious Disease In-vitro Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Infectious Disease In-vitro Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 199 Pages
  • Global
From
In Vitro Diagnostics (IVD) Quality Control - Global Strategic Business Report - Product Image

In Vitro Diagnostics (IVD) Quality Control - Global Strategic Business Report

  • Report
  • 275 Pages
  • Global
From

About the In Vitro Diagnostic Device Market

The In Vitro Diagnostic Device (IVD) market is a segment of the In Vitro Diagnostics (IVD) industry. IVD devices are used to detect, diagnose, and monitor diseases and other medical conditions. These devices are used in laboratories, hospitals, and other healthcare settings. IVD devices include instruments, reagents, and software used to analyze samples such as blood, urine, and tissue. IVD devices are used to detect a wide range of diseases, including cancer, cardiovascular disease, diabetes, and infectious diseases. They are also used to monitor the effectiveness of treatments and to assess the risk of developing certain diseases. IVD devices are developed and manufactured by a variety of companies, including Abbott, Becton Dickinson, Roche, Siemens, and Thermo Fisher Scientific. These companies provide a range of products, including instruments, reagents, and software. They also provide services such as training and technical support. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.